CERTAIN INFORMATION IDENTIFIED WITH [***] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL AND (ii) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.Agreement • March 20th, 2024 • Barinthus Biotherapeutics Plc. • Pharmaceutical preparations • England and Wales
PARTNER INFORMATION Names: The Chancellors, Masters and Scholars of the University of Oxford(“Oxford”); andBarinthus Biotherapeutics (UK) Limited, a private limited company incorporated in England and Wales with company number 09973585 (“Barinthus Bio”),(each of Oxford and Barinthus Bio a “Partner” and together the “Partners”) Mailing Address: For Oxford: University Offices, Wellington Square, Oxford, OX1 2JDFor Barinthus Bio: Barinthus Biotherapeutics (UK) Limited, Units 6 to 10 Zeus Building, Rutherford Avenue, Harwell, Oxfordshire, Didcot OX11 0DF Project Lead: For Oxford: [***]For Barinthus Bio: [***] Management Contact: For Oxford: [***]For Barinthus Bio: [***] Bank Account Details: For OxfordAccount Name: University of Oxford Account Number: [***]IBAN Number: [***]Bank Sort Code Number: [***] Swift Code: [***]Bank: [***]Bank Address: [***] For Barinthus BioAccount Name: Barinthus Biotherapeutics (UK) Limited Account Number: [***]
